🇺🇸 Cisplatin injection in United States

186 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 186

Most-reported reactions

1. Febrile Neutropenia — 54 reports (29.03%)
2. Product Use In Unapproved Indication — 23 reports (12.37%)
3. Pyrexia — 19 reports (10.22%)
4. Neutropenia — 16 reports (8.6%)
5. Ototoxicity — 14 reports (7.53%)
6. Vomiting — 14 reports (7.53%)
7. Diarrhoea — 13 reports (6.99%)
8. Pancytopenia — 12 reports (6.45%)
9. Nausea — 11 reports (5.91%)
10. Cardiotoxicity — 10 reports (5.38%)

Source database →

Frequently asked questions

Is Cisplatin injection approved in United States?

Cisplatin injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Cisplatin injection in United States?

Guangzhou Double Bioproducts Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.